[HTML][HTML] Perception of the regulatory change for Zolpidem prescription by French general practitioners and its relation to prescription behavior
EJ Laforgue, M Istvan, B Schreck, M Mainguy… - Journal of Clinical …, 2022 - mdpi.com
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
[PDF][PDF] Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
EJ Laforgue, M Istvan, B Schreck, M Mainguy… - J. Clin. Med, 2022 - researchgate.net
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior.
EJ Laforgue, M Istvan, B Schreck… - Journal of Clinical …, 2022 - europepmc.org
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior.
EJ Laforgue, M Istvan, B Schreck… - Journal of Clinical …, 2022 - search.ebscohost.com
Background: To" limit the risk of abuse and misuse" and" encourage correct usage", the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
[PDF][PDF] Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
EJ Laforgue, M Istvan, B Schreck, M Mainguy… - J. Clin …, 2022 - pdfs.semanticscholar.org
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
EJ Laforgue, I Marion, B Schreck… - Journal of Clinical …, 2022 - search.proquest.com
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
[HTML][HTML] Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
EJ Laforgue, M Istvan, B Schreck… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
EJ Laforgue, M Istvan, B Schreck… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
M Istvan, B Schreck, M Mainguy, P Jolliet… - Journal of Clinical …, 2022 - hal.science
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
[PDF][PDF] Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
EJ Laforgue, M Istvan, B Schreck, M Mainguy, P Jolliet… - J. Clin. Med, 2022 - hal.science
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …